Brief: Adaptive Biotechnologies Reports First Quarter 2023 Financial Results
03/05/2023 23:27
May 4 (Reuters) - Adaptive Biotechnologies Q1 EPS USD -0.4 * Outlook FY revenue USD 205-215 million * Q1 revenue USD 37.6 million * Q1 operating expenses USD 94.8 million * Q1 adjusted EBITDA USD -37.1 million * Q1 net income USD -57.7 million
Recent news on Adaptive Biotechnologies
See all newsBrief: Adaptive Biotechnologies Corp - Issues $345 Million In 0% Convertible Senior Notes Due 2031 - SEC Filing
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, CME
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, AST SpaceMobile